23.03.11 00:09 Age: -198 Tage
International Events > Pharmaceuticals / Medical devices
Frankfurt/Offenbach, 23.03.2011
Regulatory Affairs China
- The SFDA and Further Authorities
- Documents for the Application
- Maintenance of the Licence
- IP Protection
Your Speakers:
-
Dr. Alan A. Chalmers
-

Pharma International,
Innovation Centre,
Schweiz
Close
-
Dr. Mónica Dressler-Meyer
-

Consultant für Regulatory Affairs, Binningen, Schweiz
Close
|
|
Seminar 1103230
Date: 23.03.2011
-
Your Contact
-

Dr. Henriette Wolf-Klein
Bereichsleiterin Pharma
E-Mail
Close
Venue:
-
Frankfurt/Offenbach
-
Sheraton Offenbach
Berliner Straße 111 63065 Frankfurt/Offenbach
Tel. +49 69 82999-0 Fax +49 69 82999-810
Close
Fee: 890,- EUR zzgl. MwSt.
|
Further Information
-
Aims and Objectives
-
China is a lucrative market for European pharmaceutical products. With more than 1,3 billion inhabitants, it is the most populous country in the world.
But what are the requirements for a successful marketing authorisation? In this seminar you will learn about
clinical trials in these countries
the drug registration procedures
dossier requirements
post-approval regulatory processes
and much more.
May we invite you to seize the opportunity to attend this meeting and get in touch with 2 industrial experts.
Close
|